These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 8853261)

  • 21. Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis.
    Trapnell BC; Maguiness K; Graff GR; Boyd D; Beckmann K; Caras S
    J Cyst Fibros; 2009 Dec; 8(6):370-7. PubMed ID: 19815466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
    Ansaldi-Balocco N; Santini B; Sarchi C
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
    Löhr JM; Hummel FM; Pirilis KT; Steinkamp G; Körner A; Henniges F
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1024-31. PubMed ID: 19352190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations].
    Lankisch PG; Lembcke B; Kirchhoff S; Hilgers R; Creutzfeldt W
    Dtsch Med Wochenschr; 1988 Jan; 113(1):15-7. PubMed ID: 3335192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Differential therapy of exocrine pancreatic insufficiency--current aspects and future prospects of substitution therapy with pancreatic enzymes].
    Löser C; Fölsch UR
    Z Gastroenterol; 1995 Dec; 33(12):715-22. PubMed ID: 8585255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective analysis to investigate the effect of concomitant use of gastric acid-suppressing drugs on the efficacy and safety of pancrelipase/pancreatin (CREON®) in patients with pancreatic exocrine insufficiency.
    Sander-Struckmeier S; Beckmann K; Janssen-van Solingen G; Pollack P
    Pancreas; 2013 Aug; 42(6):983-9. PubMed ID: 23587850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin.
    Neoptolemos JP; Ghaneh P; Andrén-Sandberg A; Bramhall S; Patankar R; Kleibeuker JH; Johnson CD
    Int J Pancreatol; 1999 Jun; 25(3):171-80. PubMed ID: 10453419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
    Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Experience with the use of 13C-breath test for the evaluation of the efficacy of enzyme substitution therapy with microencapsulated pancreatinin in patients with severe primary pancreatic insufficiency].
    Rapoport SI; Maev IV; Kucheriavyĭ IuA; Shubina NA; Semenova NV; Stukova NIu; Archakov AI
    Klin Med (Mosk); 2009; 87(1):53-7. PubMed ID: 19256262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction of malnutrition and maldigestion with enzyme supplementation in patients with surgical suppression of exocrine pancreatic function.
    Braga M; Cristallo M; De Franchis R; Mangiagalli A; Agape D; Primignani M; Di Carlo V
    Surg Gynecol Obstet; 1988 Dec; 167(6):485-92. PubMed ID: 3187872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of pancreatic enzyme microsphere technology and US findings with Pancrease in the treatment of chronic pancreatitis.
    DeYoung JL
    Int J Pancreatol; 1989; 5 Suppl():31-6. PubMed ID: 2702248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of pancrease: crossover comparative study versus eurobiol in cystic fibrosis.
    Chazalette JP; Dain MP; Castaigne JP
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S46-8. PubMed ID: 3042939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis.
    Safdi M; Bekal PK; Martin S; Saeed ZA; Burton F; Toskes PP
    Pancreas; 2006 Aug; 33(2):156-62. PubMed ID: 16868481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study.
    Colombo C; Fredella C; Russo MC; Faelli N; Motta V; Valmarana L; Longo L; D'Orazio C
    Pancreas; 2009 Aug; 38(6):693-9. PubMed ID: 19531972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy with pancreatic enzyme preparations].
    Holtmann G; Layer P
    Med Monatsschr Pharm; 1993 Feb; 16(2):38-42. PubMed ID: 8441359
    [No Abstract]   [Full Text] [Related]  

  • 36. Enteric-coated pancreatic enzyme with bicarbonate is equal to standard enteric-coated enzyme in treating malabsorption in cystic fibrosis.
    Kalnins D; Ellis L; Corey M; Pencharz PB; Stewart C; Tullis E; Durie PR
    J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):256-61. PubMed ID: 16540792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of lower than standard doses of pancreatic enzyme supplementation therapy during acid inhibition in patients with pancreatic exocrine insufficiency.
    Vecht J; Symersky T; Lamers CB; Masclee AA
    J Clin Gastroenterol; 2006 Sep; 40(8):721-5. PubMed ID: 16940886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)].
    Gottschalk B; Wiesemann HG; Stephan U
    Monatsschr Kinderheilkd; 1988 Sep; 136(9):626-9. PubMed ID: 3237230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
    Löser C; Fölsch UR
    Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study.
    Domínguez-Muñoz JE; Iglesias-García J; Iglesias-Rey M; Figueiras A; Vilariño-Insua M
    Aliment Pharmacol Ther; 2005 Apr; 21(8):993-1000. PubMed ID: 15813835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.